Advertisement

Topics

BioRobotics Limited Company Profile

13:19 EDT 24th September 2018 | BioPortfolio

BioRobotics was founded as a privately funded venture with the aim of providing quality solutions to automation and robotics in the field of molecular biology. The BioPick, the company’s first product, is used for the generation of genomic libraries. Capable of picking randomly grown colonies of yeast, Escherichia coli or phage into 96 or 384 well microtitre plates, the instrument runs unattended for up to 10 hours. In this time it will pick up to 10,000 clones and inoculate them into microplates, which are filled with media on-line. The BioGrid was added to the range in 1996. Compact sized, but with high throughput and capacity it is used to produce gridded arrays on membranes. This year BioRobotics has added the MicroGrid, an adaptation of the BioGrid, which allows the generation of custom microarrays of nucleic acids on solid substrates. A team of professional engineers and biologists work together to create optimised solutions to specific problems, and it is this multidisciplinary approach that has resulted in machines that are reliable, compact, easy to use and competitively priced. Distributor agreements are in place in Japan, Taiwan, China, Korea, New Zealand and Australia. There is a subsidiary company in Boston, MA, USA, and sales and marketing is direct from the UK to the rest of the world. BioRobotics has the long-term aim of continuing to grow through new product development funded from income. Ideas for further products are continually being evaluated.



BioRobotics BioPick BioGrid BioFill MicroGrid Automation Molecular Biology Genetics Genomics Instrumentation Colony Picking Gridding Membranes Filters Micro-array

Location

Barton RoadHaslingfield
Cambridge
Cambridgeshire
CB3 7LW
United Kingdom

Contact

Phone: 44 1223 873500
Fax: 44 1223 873589


News Articles [31 Associated News Articles listed on BioPortfolio]

Procept BioRobotics’ BPH treatment Aquablation meets primary endpoints in phase III study

Procept BioRobotics’ benign prostatic hyperplasia (BPH) treatment Aquablation therapy has met its primary safety and efficacy endpoints in the global phase III waterjet ablation therapy for endoscop...

Trial of Procept BioRobotics' BPH therapy meets endpoints

A 101-patient single-arm, prospective study conducted at 16 US and Canadian sites achieved its primary efficacy and safety en -More- 

PROCEPT BioRobotics Named 2018 MedTech Breakthrough Award Winner

PROCEPT BioRobotics’ AQUABEAM System Recognized with “Best Healthcare Robotics Solution” Award PROCEPT BioRobotics today announced that it has been sele...

WATER Study One-Year Data and WATER II Primary Endpoint Data for PROCEPT BioRobotics’ Aquablation® Therapy to be Presented at AUA 2018

PROCEPT BioRobotics, a Silicon Valley surgical robotics company developing novel and disruptive technologies to treat prostate disease, announced today that the company’s...

PROCEPT BioRobotics’ Aquablation Meets Primary Endpoints in WATER II Study of 80 to 150 Milliliter Prostates

Procedure Confirmed as a Safe, Effective, Heat-Free Treatment of BPH in a Broad Range of Prostates PROCEPT BioRobotics, a Silicon Valley robotics company deve...

Quotient Limited Announces Details of Investor Day

JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ he...

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

Genetic Technologies Limited: Project Shivom Strategic Alliance

MELBOURNE, Australia, March 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG)  (NASDAQ:GENE) (“Company”, “GTG”) a diversified molecular diagnostics company; provider of...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Enhanced Skeletal Muscle Formation on Microfluidic Spun Gelatin Methacryloyl (GelMA) Fibers Using Surface Patterning and Agrin Treatment.

Bioengineered functional muscle tissues are beneficial for regenerative medicine due to their treatment potential for various debilitating disorders, including myopathy and traumatic injuries. However...

Clinical Trials [0 Results]

None

Companies [85 Associated Companies listed on BioPortfolio]

PROCEPT BioRobotics

Based in Silicon Valley, PROCEPT BioRobotics is a privately held surgical robotics company enabling better patient care by developing transformative solutions in urology. With an ...

BioRobotics Limited

BioRobotics was founded as a privately funded venture with the aim of providing quality solutions to automation and robotics in the field of molecular biology. The BioPick, the company’s first produ...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

More Information about "BioRobotics Limited" on BioPortfolio

We have published hundreds of BioRobotics Limited news stories on BioPortfolio along with dozens of BioRobotics Limited Clinical Trials and PubMed Articles about BioRobotics Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioRobotics Limited Companies in our database. You can also find out about relevant BioRobotics Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record